Table II.

Days of treatment per 1000 intensive care-adjusted patient-days

Antimicrobial	Total	1st wave	2nd wave
Meropenem	86.73	129.55	55.33
Ceftazidime	93.08	69.55	110.33
Cephalosporin/β-lactamase inhibitors	1.92	0.00	3.33
Other cephalosporins	26.92	26.82	27.00
Co-amoxiclav	31.35	45.45	21.00
Piperacillin–tazobactam	137.50	150.00	128.33
Other penicillins	25.77	28.18	24.00
Glycopeptides	127.12	127.27	127.00
Aminoglycosides	22.12	21.36	22.67
Clarithromycin	26.92	52.73	8.00
Erythromycin	9.81	8.64	10.67
Ciprofloxacin	87.31	82.73	90.67
Other antibacterials	44.81	45.91	44.00
Aciclovir	53.65	80.45	34.00
Remdesivir	33.85	14.09	48.33
Other antivirals	8.46	3.64	12.00
Caspofungin	32.69	49.09	20.67
Fluconazole	7.69	9.55	6.33
Liposomal amphotericin	8.65	10.91	7.00
Other antifungals	5.77	6.23	5.43
No anti-infective	439.23	450.00	431.33